Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787318 · ClinicalTrials.gov registry record · Early Phase 1
Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 10
- Enrollment target
NCT01787318 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 10 participants.
The verdict
NCT01787318, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This research study designed to look at how well adolescents' and young adults' blood sugars can be controlled with a "closed loop artificial pancreas" using a continuous glucose sensor, an insulin pump, and a computer program that automatically determines how much insulin to give based on the glucose level. The investigators will also study the effect of wearing a small heating patch, the InsuPatch, at the site of insulin infusion, on the ability of the closed loop system to control the blood sugar levels and to reduce the rise in glucose levels after meals.
Interventions
- DEVICE InsuPatch
- DEVICE ePID closed loop system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01787318
The ClinicalTrials.gov registry entry for NCT01787318 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which InsuPatch is the first listed.
NCT01787318 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01787318 about?
NCT01787318 is a clinical study titled "Effect of the InsuPatch on Automated Closed-loop Glucose Control in Type 1 Diabetes". This research study designed to look at how well adolescents' and young adults' blood sugars can be controlled with a "closed loop artificial pancreas" using a continuous glucose sensor, an insulin pump, and a computer program that automatically determines how much insulin to give based on the gluco...
What is the current status of trial NCT01787318?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2013-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01787318?
The interventions under investigation include: InsuPatch (DEVICE), ePID closed loop system (DEVICE).
Who is sponsoring clinical trial NCT01787318?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.